SALT LAKE CITY, Feb. 27, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Heather Ramsay, Ph.D. as Scientific Director.
"Dr. Ramsay's extensive expertise constitutes an undeniable asset to the further development of Numira's industry-leading products and technology," affirmed Hal Widlansky, CEO of Numira. "Her exceptional work in orthopaedics and skeletal biology has brought her many accolades. We will be working together to advance our technology and scientific expertise and supplement our client's research capabilities."
With nearly 20 years of experience in biomedical research, working predominately in the fields of human skeletal biology, orthopedics, and wound healing, Dr. Ramsay joins the Numira team, broadly providing scientific expertise in support of the sales team. Her research has included both animal models and human skeletal remains, modern and archaeological.
Prior to Numira, Heather's professional experience includes 2 years as a Principal Investigator at Histion, a CRO that specializes in hard tissue and device histology. Additionally, she served 4 years as Director of Orthopaedics at MPI Research, 4 years as Study Director in Orthopaedics at MDS Pharma Services, and 10 years as an academic researcher in skeletal biology at both the University of Missouri-Columbia and Wake Forest University. Heather received a Ph.D. in Biological Anthropology, focusing on the bio-behavioral emergence of osteoporosis in humans, from the University of Missouri-Columbia and a Master's in Biological Anthropology from Wake Forest University.
"I am very honored to be appointed Scientific Director at Numira," said Dr. Ramsay. "I look forward to fostering and promoting innovative research, and working with our sales representatives to showcase our cutting-edge technology and leading scientific thinking to the biotechnology community. The top notch scientific teams at both our sites are cohesive and energetic, and I am excited to further our technology into new fields of research."
Numira is a specialized preclinical contract research organization (CRO) assisting pharmaceutical, biotech, and medical device companies to understand the efficacy of their products at the early stages of development. Utilizing patented imaging protocols and 3D quantitative analysis tools, Numira delivers images, metrics, and analyses that provide definitive results rapidly and accurately. Focused on therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation, Numira's novel customized solutions provide researchers with new insights and greater accuracy in a cost-effective and timely manner, helping to expedite the discovery process. For more information visit www.numira.com.
Email: [email protected]